Novel drug prevents common viral disease in stem-cell transplant patients, study finds

A new drug can often prevent a common, sometimes severe viral disease in patients receiving a transplant of donated blood-making stem cells, a clinical trial led by researchers at Dana-Farber Cancer Institute and Brigham and Women's Hospital indicates.

http://www.eurekalert.org/pub_releases/2013-09/dci-ndp092413.php